GO:1905061 negative regulation of cardioblast proliferation: Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905061 describes any process that stops, prevents or reduces the frequency, rate or extent of cardioblast proliferation.
• Cardioblast proliferation is a key step in heart development, and its negative regulation ensures correct cell numbers and chamber formation.
• The GTPase Rac1 has a dual role in cardiac differentiation of stem cells, including effects on proliferation.
• Dysregulation of cardioblast proliferation is linked to congenital heart defects and altered cardiac regeneration.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of genes controlling cardioblast proliferation.
• Understanding negative regulation of cardioblast proliferation informs strategies for cardiac repair and disease modeling.
Description
Cardioblast proliferation is the process by which cardiac progenitor cells divide to expand the pool of cells that will form the heart. Negative regulation of cardioblast proliferation (GO:1905061) refers to any process that stops, prevents or reduces the frequency, rate or extent of this proliferation. This regulatory step is essential for balancing cardiac cell numbers during development and for preventing excessive or insufficient growth that can lead to congenital heart defects. Researchers study this process to understand how signaling pathways and transcription factors control heart size and to identify targets for regenerative medicine. The GTPase Rac1 has been shown to play a dual role in cardiac differentiation of stem cells, influencing both proliferation and differentiation decisions. This article synthesizes current knowledge on GO:1905061, covering its definition, mechanisms, key genes, disease relevance, and experimental approaches including CRISPR-based models.
negative regulation of cardioblast proliferation At A Glance
| GO ID | GO:1905061 |
|---|---|
| GO term | negative regulation of cardioblast proliferation |
| Ontology | biological_process |
| Synonym | down regulation of cardioblast proliferation, down-regulation of cardioblast proliferation, downregulation of cardioblast proliferation, inhibition of cardioblast proliferation |
| Major function | Limits the number of cardioblasts by reducing their proliferation rate, ensuring proper heart size and function |
| Related process | Cardiac differentiation, cell cycle arrest, heart morphogenesis |
| Key regulator example | Rac1 GTPase |
| Disease relevance | Congenital heart defects, cardiac regeneration failure |
What Is GO:1905061?
GO:1905061 (negative regulation of cardioblast proliferation) is a biological process term defined as any process that stops, prevents or reduces the frequency, rate or extent of cardioblast proliferation. Cardioblasts are embryonic cells that give rise to the heart. This term encompasses molecular signals, such as growth factor withdrawal, cell cycle inhibitors, and differentiation cues, that limit the division of these progenitor cells.
Why Is negative regulation of cardioblast proliferation Important in Cell Biology?
Negative regulation of cardioblast proliferation is critical for normal heart development because it prevents excessive cardiac progenitor expansion, which can lead to malformed hearts, and it promotes timely differentiation into cardiomyocytes. Disruption of this process is associated with congenital heart defects and impaired cardiac regeneration after injury. Understanding the molecular players, such as Rac1, provides insights into both developmental biology and potential therapeutic strategies for heart disease.
• Ensures correct heart size and chamber formation during embryogenesis.
• Prevents tumor-like overgrowth of cardiac progenitor cells.
• Facilitates the transition from proliferation to differentiation in cardioblasts.
• Its dysregulation is linked to congenital heart defects.
• Influences cardiac regeneration capacity in adult organisms.
• Provides targets for regenerative medicine and tissue engineering.
• Helps understand signaling pathways like Rac1 in cardiac development.
• Aids in modeling human heart diseases using stem cells.
What Happens During negative regulation of cardioblast proliferation?
Initiation by extracellular signals
In simple terms: Signals from outside the cell tell cardioblasts to stop dividing.
Negative regulation of cardioblast proliferation often begins with extracellular cues such as reduced growth factor availability or inhibitory signals from neighboring tissues. These signals activate intracellular pathways that ultimately halt the cell cycle.
Intracellular signaling cascades
In simple terms: Inside the cell, a chain of molecular switches relays the stop signal.
The GTPase Rac1 has been implicated in cardiac differentiation of stem cells, where it can modulate proliferation through effects on actin dynamics and gene expression. Other pathways, such as Notch and Wnt, may also contribute, though specific evidence in cardioblasts is still emerging.
Cell cycle arrest
In simple terms: The machinery that drives cell division is put on hold.
Ultimately, negative regulation leads to cell cycle exit, often involving upregulation of cyclin-dependent kinase inhibitors and downregulation of proliferative genes. This arrest is a prerequisite for cardioblast differentiation into cardiomyocytes.
Commitment to differentiation
In simple terms: Once division stops, cardioblasts mature into heart muscle cells.
After proliferation ceases, cardioblasts undergo differentiation, expressing cardiac-specific genes and forming functional contractile units. This transition is tightly coordinated with the negative regulation of proliferation to ensure proper heart development.
Key Genes Involved in GO:1905061 negative regulation of cardioblast proliferation
The following genes and proteins have been associated with the regulation of cardioblast proliferation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Rac1 | GTPase involved in cardiac differentiation and proliferation control | Dual role in stem cell-derived cardiogenesis; knockout and overexpression models |
| Nkx2-5 | Cardiac transcription factor | Mutations linked to congenital heart defects; regulates proliferation genes |
| Gata4 | Cardiac transcription factor | Essential for heart development; influences proliferation and differentiation |
| Tbx5 | Transcription factor | Associated with Holt-Oram syndrome; affects cardioblast proliferation |
| Mef2c | Transcription factor | Promotes differentiation; may indirectly limit proliferation |
| Hand2 | Transcription factor | Regulates cardiac growth and proliferation |
| Notch1 | Signaling receptor | Controls progenitor proliferation in the heart |
| Wnt3a | Secreted signaling molecule | Modulates cardiac progenitor proliferation |
| Bmp4 | Growth factor | Influences cardioblast proliferation and differentiation |
| Fgf8 | Growth factor | Regulates cardiac progenitor expansion |
| Cyclin D1 | Cell cycle regulator | Promotes proliferation; its downregulation contributes to negative regulation |
| p21 | CDK inhibitor | Induces cell cycle arrest in cardioblasts |
| p27 | CDK inhibitor | Limits cardioblast proliferation |
| Meis1 | Transcription factor | Restricts cardiomyocyte proliferation |
| Hippo/Yap | Signaling pathway | Controls organ size including heart; Yap promotes proliferation |
| Srf | Transcription factor | Regulates cardiac gene expression and proliferation |
| Myocd | Transcription cofactor | Promotes smooth muscle and cardiac differentiation |
| Isl1 | Transcription factor | Marks cardiac progenitors; regulates proliferation |
How Is negative regulation of cardioblast proliferation Regulated?
Negative regulation of cardioblast proliferation is controlled by a network of signaling pathways and transcription factors. The GTPase Rac1 has been shown to have a dual role in cardiac differentiation of stem cells, influencing both proliferation and differentiation. Other pathways, such as Notch, Wnt, and Hippo, are known to regulate cardiac progenitor proliferation in various contexts. These pathways integrate developmental cues to ensure appropriate heart size and function.
negative regulation of cardioblast proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Rac1 | Cardiac differentiation defects | Knockout and overexpression in stem cell-derived cardiomyocytes |
| Nkx2-5 | Congenital heart defects | Point mutation knock-in mice |
| Gata4 | Congenital heart defects | Knockout and knock-in models |
| Tbx5 | Holt-Oram syndrome | Patient-derived iPSCs with point mutations |
| Meis1 | Cardiac regeneration failure | Overexpression and knockout in mice |
Congenital heart defects
Disruption of negative regulation of cardioblast proliferation can lead to excessive or insufficient cardiac progenitor expansion, resulting in structural heart defects. Mutations in cardiac transcription factors such as Nkx2-5 and Gata4 are associated with congenital heart disease.
Cardiac regeneration failure
In adult mammals, cardiomyocytes largely lose proliferative capacity, contributing to poor heart regeneration after injury. Understanding the negative regulation of cardioblast proliferation may reveal ways to reawaken regeneration.
Cardiac hypertrophy
Altered proliferation control during development can affect cardiomyocyte number and size, potentially predisposing to hypertrophic responses later in life.
From negative regulation of cardioblast proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate cardioblast proliferation? | CRISPR knockout in cardiac progenitor cells |
| Does a specific point mutation in gene X affect proliferation? | CRISPR point mutation knock-in |
| What is the effect of tagging gene X on its function? | CRISPR knock-in of fluorescent or epitope tag |
| Does overexpression of gene X reduce proliferation? | CRISPR activation or cDNA overexpression |
| Which genes are essential for negative regulation? | Genome-wide CRISPR library screening |
| How does gene X mutation affect heart development in vivo? | Mouse models with conditional knockout |
How to Study the negative regulation of cardioblast proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Identify genes required for negative regulation |
| CRISPR activation | Gain of gene function | Test if overexpression reduces proliferation |
| RNA-seq | Transcriptome changes | Discover pathways involved in proliferation arrest |
| Ribo-seq | Translation efficiency | Assess global protein synthesis during arrest |
| Proteomics | Protein abundance and modifications | Find effectors of negative regulation |
| Live-cell imaging | Proliferation dynamics | Monitor cardioblast division in real time |
| Flow cytometry | Cell cycle distribution | Quantify proliferating vs. arrested cells |
| ChIP-seq | Transcription factor binding | Map regulatory elements controlling proliferation genes |
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that negatively regulate cardioblast proliferation. These screens use pooled sgRNA libraries and selection for proliferation phenotypes.
Transcriptomics
RNA-seq of cardioblasts under conditions that stop proliferation can reveal changes in gene expression, highlighting pathways involved in negative regulation.
Imaging and proliferation assays
Live-cell imaging with fluorescent reporters for cell cycle and proliferation markers allows real-time monitoring of cardioblast division and arrest.
Proteomics
Mass spectrometry-based proteomics can identify protein interactions and post-translational modifications that mediate negative regulation of proliferation.
How CRISPR Can Be Used to Study GO:1905061 negative regulation of cardioblast proliferation
Knockout
CRISPR knockout of candidate genes in cardiac progenitor cells can test whether they are necessary for negative regulation of cardioblast proliferation. For example, knocking out Rac1 may alter proliferation dynamics.
Point Mutation
Introducing specific point mutations via CRISPR can model human variants associated with congenital heart defects and assess their impact on cardioblast proliferation.
Knock-in
Knock-in of reporter genes or tags allows visualization and tracking of cardioblasts and their proliferation status in vitro and in vivo.
Overexpression
CRISPR activation or cDNA overexpression can force expression of candidate genes to test if they are sufficient to stop cardioblast proliferation.
How EDITGENE Supports negative regulation of cardioblast proliferation Research
Researchers studying negative regulation of cardioblast proliferation-related genes often need to determine whether a candidate gene is causally involved in limiting progenitor division or is merely correlated with the process. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of cardioblast proliferation research.
Frequently Asked Questions About negative regulation of cardioblast proliferation
What is negative regulation of cardioblast proliferation?
It is any process that stops, prevents or reduces the frequency, rate or extent of cardioblast proliferation, as defined by GO:1905061.
What genes are involved in negative regulation of cardioblast proliferation?
Genes such as Rac1, Nkx2-5, Gata4, Tbx5, and Meis1 have been implicated in regulating cardioblast proliferation.
Why is negative regulation of cardioblast proliferation important?
It ensures proper heart size and prevents congenital heart defects by balancing progenitor expansion and differentiation.
How is negative regulation of cardioblast proliferation studied?
Researchers use CRISPR knockout, overexpression, RNA-seq, imaging, and proteomics to dissect the process.
What diseases are associated with defects in this process?
Congenital heart defects and cardiac regeneration failure are linked to dysregulation of cardioblast proliferation.
What is the role of Rac1 in cardioblast proliferation?
Rac1 has a dual role in cardiac differentiation of stem cells, influencing proliferation and differentiation decisions.
Can CRISPR be used to study negative regulation of cardioblast proliferation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for functional studies.
What are the synonyms for GO:1905061?
Synonyms include down regulation of cardioblast proliferation, down-regulation of cardioblast proliferation, downregulation of cardioblast proliferation, and inhibition of cardioblast proliferation.
Which GO aspect does GO:1905061 belong to?
It belongs to the biological_process ontology.
How does negative regulation of cardioblast proliferation affect heart development?
It controls the number of cardioblasts that differentiate into cardiomyocytes, which is critical for normal heart morphogenesis.
Conclusion
Negative regulation of cardioblast proliferation (GO:1905061) is a fundamental biological process that ensures proper heart development by limiting the expansion of cardiac progenitor cells. Key regulators such as Rac1 and cardiac transcription factors orchestrate this process, and its dysregulation contributes to congenital heart defects and impaired regeneration. Advances in CRISPR-based models and multi-omics approaches are accelerating our understanding of this process, offering potential therapeutic avenues for heart disease.
References
- 1. Pucéat M et al.. 2003. A dual role of the GTPase Rac in cardiac differentiation of stem cells.. Mol Biol Cell 14(7):2781-92 PMID: 12857864
